XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
OPERATING ACTIVITIES:            
Net loss $ (30,737)   $ (6,683) $ (58,761) $ (12,247)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:            
Provision for bad debt   $ 6,300   6,445 590 $ 1,246
Depreciation and amortization 9,740   7,412 27,084 20,262  
Stock-based compensation expense 1,149   1,055 3,439 3,577  
Fair value changes in the contingent put option (26,265)     (19,240)    
Fair value changes in the compound embedded option 26,664     27,420    
Fair value changes in business acquisitions contingent consideration 13,404   256 17,387 (670)  
Fair value changes in the warrant options 9,311   2,510 9,312 4,059  
Deferred income taxes       (1,563) (1,308)  
Cloud computing costs       (2,350) (247)  
Other       1,170 97  
Changes in operating assets and liabilities—net of acquisitions:            
Accounts receivable and contract assets       (7,736) (2,732)  
Prepaid expenses and other current assets       (1,349) (179)  
Accounts payable and other accrued liabilities       (4,829) (95)  
Accrued payroll and benefits       6,084 1,440  
Payment of contingent consideration and other assumed purchase price obligations       (6,390)    
Net cash (used in) provided by operating activities       (3,877) 12,547  
INVESTING ACTIVITIES:            
Purchases of property and equipment       (5,366) (2,765)  
Proprietary software development       (370) (6)  
Proceeds from net working capital adjustment related to acquisitions       2,819    
Cash paid for acquisitions—net of cash acquired       (173,923) (81,370)  
Net cash used in investing activities       (176,840) (84,141)  
FINANCING ACTIVITIES:            
Proceeds from line of credit       104,390 149,744  
Payments on line of credit       (201,980) (69,744)  
Proceeds from term loans       175,000    
Repayment of term loan       (49,297)    
Payment of contingent consideration and other purchase price obligations       (6,004) (1,136)  
Repayment of capital leases       (2,257) (1,304)  
Proceeds from issuance of common stock in connection with initial public offering, net of issuance costs       161,288    
Payments of deferred offering costs       (2,925) (29)  
Debt issuance costs       (4,866) (417)  
Debt extinguishment costs       (351)    
Proceeds from issuance of common stock       171 139  
Issuance of convertible and redeemable Series A-2 preferred stock and warrant       173,664    
Redemption of the Series A-1 Preferred Stock       (131,821)    
Dividend payment to the Series A-2 shareholders       (2,870)    
Exercise of warrant options       25    
Net cash provided by financing activities       212,167 77,253  
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH       31,450 5,659  
Foreign exchange impact on cash balance       43 (5)  
Beginning of year   $ 6,884   6,884 2,489 2,489
End of period $ 38,377   $ 8,143 38,377 8,143 $ 6,884
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:            
Cash paid for interest       9,368 2,689  
Cash paid for income tax       171 878  
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:            
Series A-1 preferred stock deemed dividend—net of return from holders       24,341    
Series A-1 preferred stock dividend paid in common shares       26,801    
Accrued purchases of property and equipment       486 932  
Property and equipment acquired under capital leases       1,753 2,757  
Accretion of the redeemable series A-1 preferred stock to redeemable value       17,601 14,341  
Common stock issued to acquire new businesses       25,000 4,047  
Acquisitions unpaid contingent consideration       58,912 $ 5,401  
Offering costs included in accounts payable and other accrued liabilities       $ 1,237